TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33683403

Group type: EXPERIMENTAL
Intervention: Sonified action observation and motor imagery (AOMI)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Non-sonified action observation and motor imagery (AOMI)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Auditory paired associative stimulation (aPAS) completed alone
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Auditory paired associative stimulation (aPAS) primed by practice block
Number of subjects: 19
Study: 32443290

Group type: EXPERIMENTAL
Intervention: PLIF
Number of subjects: 143

Group type: COMPARATOR
Intervention: TLIF
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: Comparison of PLIF and TLIF
Number of subjects: 143
Study: 35866347

Group type: EXPERIMENTAL
Intervention: RM + PEEP−EIT
Number of subjects: 60

Group type: COMPARATOR
Intervention: PEEP−EIT
Number of subjects: 60
Study: 33866666

Group type: EXPERIMENTAL
Intervention: Test toothpaste containing natural ingredients (clove, aloe vera, amla, neem, tulsi, honey) with zinc salts and fluoride
Number of subjects: 180

Group type: COMPARATOR
Intervention: Control toothpaste formulated with fluoride alone
Number of subjects: 180
Study: 32289741

Group type: EXPERIMENTAL
Intervention: Dulaglutide 1.5 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Gliclazide 60 mg
Number of subjects: 0
Study: 35689278

Group type: EXPERIMENTAL
Intervention: New type of CPM machine for 2 weeks post-operative rehabilitation
Number of subjects: 126

Group type: COMPARATOR
Intervention: Conventional CPM machine for 2 weeks post-operative rehabilitation
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Both types of CPM machines for 2 weeks post-operative rehabilitation
Number of subjects: 126
Study: 33287271

Group type: EXPERIMENTAL
Intervention: L-band PALSAR-2
Number of subjects: 0

Group type: COMPARATOR
Intervention: C-band Sentinel-1
Number of subjects: 0
Study: 35730655

Group type: EXPERIMENTAL
Intervention: Positive mind-set induction
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Negative mind-set induction
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no mind-set induction)
Number of subjects: 0
Study: 32871403

Group type: EXPERIMENTAL
Intervention: Homemade smoothie A
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Homemade smoothie B
Number of subjects: 20

Group type: COMPARATOR
Intervention: Commercial smoothie
Number of subjects: 20
Study: 35787426

Group type: EXPERIMENTAL
Intervention: PFOA
Number of subjects: 3175

Group type: EXPERIMENTAL
Intervention: PFOA and PFOS (joint effect)
Number of subjects: 3175

Group type: EXPERIMENTAL
Intervention: PFOA and PFOS
Number of subjects: 3175

Group type: COMPARATOR
Intervention: PFOS
Number of subjects: 3175
Study: 33060436

Group type: EXPERIMENTAL
Intervention: Oral vitamin D3, 2000 IU/day for 6 months
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 32102108

Group type: EXPERIMENTAL
Intervention: Electronic alert for vitamin D assay orders
Number of subjects: 12368

Group type: COMPARATOR
Intervention: No electronic alert for vitamin D assay orders (Control)
Number of subjects: 12368
Study: 35094694

Group type: EXPERIMENTAL
Intervention: One meat-free, three meat options
Number of subjects: 2205

Group type: EXPERIMENTAL
Intervention: Two meat-free, two meat options
Number of subjects: 2205

Group type: EXPERIMENTAL
Intervention: Three meat-free, one meat option
Number of subjects: 2205

Group type: EXPERIMENTAL
Intervention: Increasing the availability of meat-free options
Number of subjects: 2205

Group type: EXPERIMENTAL
Intervention: Altering the ratio of meat-free meals in university cafeteria
Number of subjects: 2205

Group type: EXPERIMENTAL
Intervention: Menu change in 18 worksite cafeterias
Number of subjects: 2205
Study: 34083338

Group type: EXPERIMENTAL
Intervention: Relating Therapy (RT) plus Treatment as Usual (TAU)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Treatment as Usual (TAU) alone
Number of subjects: 75
Study: 36383175

Group type: EXPERIMENTAL
Intervention: Tocilizumab and glucocorticoids
Number of subjects: 209

Group type: COMPARATOR
Intervention: Glucocorticoids only
Number of subjects: 209
Study: 32981536

Group type: EXPERIMENTAL
Intervention: Vitamin C (500 mg slow-release)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control (inactive placebo)
Number of subjects: 16
Study: 32351205

Group type: EXPERIMENTAL
Intervention: Esmirtazapine 4.5 mg
Number of subjects: 457

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 457

Group type: EXPERIMENTAL
Intervention: Esmirtazapine 4.5 mg (in open-label extension)
Number of subjects: 457
Study: 35960649

Group type: EXPERIMENTAL
Intervention: Spinal anaesthesia (SSS, bupivacaine 0.5% + fentanyl)
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: Bilateral transversus abdominis plane block (TAP, ropivacaine 0.375% + clonidine)
Number of subjects: 133

Group type: COMPARATOR
Intervention: Systemic administration of lidocaine (SA, lidocaine 1%)
Number of subjects: 133
Study: 34057096

Group type: EXPERIMENTAL
Intervention: Short pulse deep brain stimulation (spDBS) with 40μs pulse width
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Conventional deep brain stimulation (cDBS) with 60μs pulse width
Number of subjects: 20

Group type: COMPARATOR
Intervention: DBS stimulation switched off (off DBS)
Number of subjects: 20
Study: 34176847

Group type: EXPERIMENTAL
Intervention: Thermoplastic resin removable partial dentures (TR‐RPDs)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Metal‐clasp‐retained removable partial dentures (MC‐RPDs)
Number of subjects: 28
Study: 33487259

Group type: EXPERIMENTAL
Intervention: Intramuscular injection of 300,000 IU vitamin D3
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 60
Study: 36369266

Group type: EXPERIMENTAL
Intervention: DLDL-RF hybrid model
Number of subjects: 0

Group type: COMPARATOR
Intervention: CNN-GRU model
Number of subjects: 0
Study: 34530750

Group type: EXPERIMENTAL
Intervention: Probiotics
Number of subjects: 248

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 248
Study: 33358107

Group type: EXPERIMENTAL
Intervention: Erector Spinae Plane Block (ESPB)
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Thoracic Paravertebral Block (TPVB)
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Intercostal Nerve Block (ICNB)
Number of subjects: 106
Study: 32064725

Group type: EXPERIMENTAL
Intervention: CIN-Zn (756.6 μmol/L cinnamaldehyde and 70 μmol/L zinc)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: CIT (1.6 mmol/L citral)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: CIT-ISO (1.6 mmol/L citral and 1.3 mmol/L isopulegol)
Number of subjects: 58
Study: 36036546

Group type: EXPERIMENTAL
Intervention: ILR group (implantable loop recorder screening for AF)
Number of subjects: 6004

Group type: COMPARATOR
Intervention: Control group (usual care)
Number of subjects: 6004

Group type: EXPERIMENTAL
Intervention: ILR group
Number of subjects: 6004

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 6004

Group type: EXPERIMENTAL
Intervention: ILR group (participants without prior stroke)
Number of subjects: 6004
Study: 34933717

Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical nerve stimulation (TENS)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Analgesic drugs
Number of subjects: 70
Study: 35605426

Group type: EXPERIMENTAL
Intervention: Intravenous labetalol (20 mg; 40 mg; 80 mg; 80 mg; and 80 mg)
Number of subjects: 113

Group type: COMPARATOR
Intervention: Intravenous hydralazine (10 mg, up to 5 doses)
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Intravenous labetalol
Number of subjects: 113

Group type: COMPARATOR
Intervention: Intravenous hydralazine
Number of subjects: 113
Study: 33709237

Group type: EXPERIMENTAL
Intervention: High suspension and low incision (HSLI) surgery
Number of subjects: 246

Group type: COMPARATOR
Intervention: Milligan‐Morgan haemorrhoidectomy
Number of subjects: 246
Study: 32925039

Group type: EXPERIMENTAL
Intervention: Aerobic Exercise (AE)
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: DASH diet
Number of subjects: 132

Group type: COMPARATOR
Intervention: Health Education Control (HE)
Number of subjects: 132
Study: 36302125

Group type: COMPARATOR
Intervention: ABI-H2158 (100, 300, or 500 mg QD or 300 mg BID)
Number of subjects: 93

Group type: COMPARATOR
Intervention: ABI-H2158 (5-500 mg single ascending dose)
Number of subjects: 93

Group type: COMPARATOR
Intervention: ABI-H2158 (300 mg QD or BID for 10 days)
Number of subjects: 93

Group type: COMPARATOR
Intervention: ABI-H2158 (300 mg QD for 14 days)
Number of subjects: 93
Study: 33474705

Group type: EXPERIMENTAL
Intervention: Daratumumab monotherapy
Number of subjects: 31
Study: 35387759

Group type: EXPERIMENTAL
Intervention: 900 mg Ursodeoxycholic acid (UDCA) for 6 months
Number of subjects: 967

Group type: COMPARATOR
Intervention: Placebo for 6 months
Number of subjects: 967
Study: 34224554

Group type: EXPERIMENTAL
Intervention: Wheat bran with reduced particle size (WB RPS), 20 g daily for 1 month
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Wheat bran with reduced particle size (WB RPS)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo (maltodextrin)
Number of subjects: 14
Study: 34674667

Group type: EXPERIMENTAL
Intervention: Oral sodium bicarbonate tablets titrated up to a maximum of 3 g bd (6 g total) for 12 weeks
Number of subjects: 43

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 43
Study: 32757595

Group type: EXPERIMENTAL
Intervention: Targeted intervention
Number of subjects: 76

Group type: COMPARATOR
Intervention: Ask, advise, refer (AAR)
Number of subjects: 76
Study: 33650265

Group type: EXPERIMENTAL
Intervention: Systemic inflammatory response (SIR) biomarkers
Number of subjects: 4199
Study: 33513734

Group type: EXPERIMENTAL
Intervention: Meat-based complementary diet
Number of subjects: 0

Group type: COMPARATOR
Intervention: Dairy-based complementary diet
Number of subjects: 0
Study: 34740020

Group type: EXPERIMENTAL
Intervention: HCV communication with alters currently enrolled in drug treatment
Number of subjects: 227

Group type: EXPERIMENTAL
Intervention: HCV communication with alters sharing drug preparation equipment
Number of subjects: 227

Group type: EXPERIMENTAL
Intervention: HCV communication with alters who are sex partners compared to kin
Number of subjects: 227

Group type: EXPERIMENTAL
Intervention: HCV communication with alters with increased trust
Number of subjects: 227

Group type: EXPERIMENTAL
Intervention: HCV communication with alters with daily/weekly interactions
Number of subjects: 227
Study: 33256626

Group type: EXPERIMENTAL
Intervention: Behavioural smoking cessation intervention
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Trial Sequential Analysis
Number of subjects: 0
Study: 34030123

Group type: EXPERIMENTAL
Intervention: Physically active lessons (intervention group, n = 34)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Control classes (control group, n = 27)
Number of subjects: 61
Study: 36493792

Group type: EXPERIMENTAL
Intervention: Abemaciclib plus endocrine therapy
Number of subjects: 5637

Group type: COMPARATOR
Intervention: Endocrine therapy alone
Number of subjects: 5637
Study: 34342620

Group type: EXPERIMENTAL
Intervention: Sedation and ventilator liberation protocol intervention
Number of subjects: 8843

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 8843
Study: 36220716

Group type: EXPERIMENTAL
Intervention: 109 CFU BPZE1 via VaxINator device
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: 109 CFU BPZE1 via tuberculin syringe
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: 107 CFU BPZE1 via VaxINator device
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo via VaxINator device
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 50
Study: 33639116

Group type: EXPERIMENTAL
Intervention: Virtual reality with Nintendo Wii (VRWiiG)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Conventional physical therapy (CPTG)
Number of subjects: 29
Study: 32122821

Group type: EXPERIMENTAL
Intervention: Post-PCI IVUS assessment
Number of subjects: 603

Group type: COMPARATOR
Intervention: No post-PCI IVUS assessment
Number of subjects: 603

Group type: EXPERIMENTAL
Intervention: Lower tertile of LMS MSA
Number of subjects: 603

Group type: EXPERIMENTAL
Intervention: Upper tertile of LMS MSA
Number of subjects: 603
Study: 36053841

Group type: EXPERIMENTAL
Intervention: Open lumbar spine fusion surgery
Number of subjects: 40

Group type: COMPARATOR
Intervention: Narcotic medication
Number of subjects: 40
Study: 32930952

Group type: EXPERIMENTAL
Intervention: Deferasirox (20 mg/kg)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: BP-ANN model
Number of subjects: 28
Study: 34430189

Group type: EXPERIMENTAL
Intervention: Behavioral economic-based messages
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 34556006

Group type: EXPERIMENTAL
Intervention: Emotion-focused group therapy (EFGT)
Number of subjects: 72
Study: 32346962

Group type: EXPERIMENTAL
Intervention: Oral Tranexamic Acid (TXA) 250 mg twice daily
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Topical Tranexamic Acid (TXA)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Modified Kligman's regimen
Number of subjects: 60
Study: 35112779

Group type: EXPERIMENTAL
Intervention: Alogliptin 25 mg once daily
Number of subjects: 1088

Group type: COMPARATOR
Intervention: Acarbose 100 mg three times daily
Number of subjects: 1088

Group type: EXPERIMENTAL
Intervention: Alogliptin
Number of subjects: 1088

Group type: COMPARATOR
Intervention: Acarbose
Number of subjects: 1088
Study: 33012244

Group type: EXPERIMENTAL
Intervention: Descending Stair Exercise (DSE)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Ascending Stair Exercise (ASE)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control Group
Number of subjects: 36
Study: 616173591

Group type: EXPERIMENTAL
Intervention: Educational-supportive self-care package
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 56
Study: 36215327

Group type: EXPERIMENTAL
Intervention: Digital home exercise program (12-week duration, four exercises daily)
Number of subjects: 213

Group type: COMPARATOR
Intervention: Physiotherapy (6 to 12 sessions depending on severity)
Number of subjects: 213
Study: 32615162

Group type: EXPERIMENTAL
Intervention: Regional nodal irradiation (RNI)
Number of subjects: 183
Study: 35956337

Group type: EXPERIMENTAL
Intervention: Protein-rich, low-glycaemic meal replacement for 6 months
Number of subjects: 463

Group type: COMPARATOR
Intervention: Lifestyle intervention alone (control group)
Number of subjects: 463
Study: 33442937

Group type: EXPERIMENTAL
Intervention: Half-normal saline (HNS)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Normal saline (NS)
Number of subjects: 99
Study: 32735225

Group type: EXPERIMENTAL
Intervention: Smartphone app group (n=25)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Paper-based diary group (n=25)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 50
Study: 34961658

Group type: EXPERIMENTAL
Intervention: Radiomics signature based on preoperative multiparametric MRI features
Number of subjects: 234

Group type: EXPERIMENTAL
Intervention: Radiomics-based models
Number of subjects: 234

Group type: EXPERIMENTAL
Intervention: MR-defined extramural venous invasion (mrEMVI)
Number of subjects: 234
Study: 32954628

Group type: EXPERIMENTAL
Intervention: Printed tooth (Group 2)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Standard model tooth (Group 1)
Number of subjects: 35
Study: 32354590

Group type: EXPERIMENTAL
Intervention: Subcutaneous mepivacaine
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Cryoanalgesia
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Anesthetic cream
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control (no anesthesia)
Number of subjects: 100
Study: 35373862

Group type: EXPERIMENTAL
Intervention: DHA fish oil supplement (1491 mg DHA + 351 mg eicosapentaenoic acid per day)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study: 34254211

Group type: EXPERIMENTAL
Intervention: Follitropin delta
Number of subjects: 1326

Group type: COMPARATOR
Intervention: Follitropin alfa
Number of subjects: 1326

Group type: EXPERIMENTAL
Intervention: Follitropin delta (fresh cycles)
Number of subjects: 1326

Group type: COMPARATOR
Intervention: Follitropin alfa (fresh cycles)
Number of subjects: 1326

Group type: EXPERIMENTAL
Intervention: Follitropin delta (frozen cycles)
Number of subjects: 1326

Group type: COMPARATOR
Intervention: Follitropin alfa (frozen cycles)
Number of subjects: 1326
Study: 32880050

Group type: EXPERIMENTAL
Intervention: Cold-water immersion (CWI, 10 °C)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Thermoneutral water immersion (TWI, 24 °C)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Contrast water therapy (CWT, alternately 10 °C and 38 °C)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Active recovery only (ACT)
Number of subjects: 9
Study: 34597280

Group type: EXPERIMENTAL
Intervention: Early surgical treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nonsurgical treatment
Number of subjects: 0
Study: 33749041

Group type: EXPERIMENTAL
Intervention: DBB (Deproteinized Bovine Bone) with SA (Sandblasting + acid attack)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: DBB (Deproteinized Bovine Bone) with SA-H (Sandblasting + acid attack + immersion in 0.9% sodium chloride isotonic solution)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: DBB/BM (Deproteinized bovine bone associated with fresh autologous bone marrow) with SA (Sandblasting + acid attack)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: DBB/BM (Deproteinized bovine bone associated with fresh autologous bone marrow) with SA-H (Sandblasting + acid attack + immersion in 0.9% sodium chloride isotonic solution)
Number of subjects: 16
Study: 34562434

Group type: EXPERIMENTAL
Intervention: Reduced sedentary behavior (SB) intervention group (n=31)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Increased physical activity levels control group (n=30)
Number of subjects: 61
Study: 34226222

Group type: EXPERIMENTAL
Intervention: KTP intervention including 2-hour structured training sessions with procedure bundle and email reminders
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: KTP intervention
Number of subjects: 32
Study: 33720589

Group type: EXPERIMENTAL
Intervention: riamilovir
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: riamilovir (3 times a day)
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: riamilovir (other regimens)
Number of subjects: 270
Study: 33703855

Group type: EXPERIMENTAL
Intervention: Distal transradial access (dTRA)
Number of subjects: 204

Group type: COMPARATOR
Intervention: Conventional transradial access (cTRA)
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: Both dTRA and cTRA
Number of subjects: 204
Study: 34105256

Group type: EXPERIMENTAL
Intervention: Whole-body EMS (n=48)
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Part-body EMS (n=42)
Number of subjects: 134

Group type: COMPARATOR
Intervention: Control group (n=44)
Number of subjects: 134
Study: 32811664

Group type: EXPERIMENTAL
Intervention: Barrel Hoop plate (BHP)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Posterolateral plate (PP)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Anterolateral plate (AP)
Number of subjects: 36
Study: 34949702

Group type: EXPERIMENTAL
Intervention: Balloon drain
Number of subjects: 267

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 267
Study: 32068854

Group type: EXPERIMENTAL
Intervention: CMV shedding prevalence in children's saliva
Number of subjects: 1770

Group type: EXPERIMENTAL
Intervention: Viral load of CMV in saliva
Number of subjects: 1770

Group type: EXPERIMENTAL
Intervention: Risk factors for higher viral load
Number of subjects: 1770

Group type: EXPERIMENTAL
Intervention: CMV awareness among parents
Number of subjects: 1770
Study: 35701732

Group type: EXPERIMENTAL
Intervention: Brief hope intervention (BHI)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Control group (customized pre-dialysis education class)
Number of subjects: 72
Study: 32208045

Group type: EXPERIMENTAL
Intervention: Telephone-Assisted Self-Help (TASH) intervention (8 self-help booklets plus up to 14 counseling telephone calls)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Telephone-Assisted Self-Help (TASH) intervention
Number of subjects: 0
Study: 36444740

Group type: EXPERIMENTAL
Intervention: Metoprolol 150 mg
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study: 33409591

Group type: EXPERIMENTAL
Intervention: Sequential romosozumab-to-alendronate treatment
Number of subjects: 1

Group type: COMPARATOR
Intervention: Alendronate alone
Number of subjects: 1
Study: 32371747

Group type: EXPERIMENTAL
Intervention: Virtual Simulation (VS)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Multimedia Lecture
Number of subjects: 60
Study: 35728900

Group type: EXPERIMENTAL
Intervention: Ava-bracelet measuring respiratory rate (RR), heart rate (HR), HR variability (HRV), wrist-skin temperature (WST), and skin perfusion
Number of subjects: 1163

Group type: EXPERIMENTAL
Intervention: Long short-term memory (LSTM) based recurrent neural network (RNN) algorithm
Number of subjects: 1163
Study: 36174365

Group type: EXPERIMENTAL
Intervention: Anodal tDCS combined with cognitive training (CT)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Sham-tDCS combined with cognitive training (CT)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Anodal tDCS
Number of subjects: 25

Group type: COMPARATOR
Intervention: Sham-tDCS
Number of subjects: 25
Study: 33655526

Group type: EXPERIMENTAL
Intervention: Circuit-based physical activity intervention
Number of subjects: 193

Group type: EXPERIMENTAL
Intervention: Circuit-based physical activity intervention (girls)
Number of subjects: 193

Group type: EXPERIMENTAL
Intervention: Circuit-based physical activity intervention (obesity)
Number of subjects: 193

Group type: COMPARATOR
Intervention: TAU (PE class as usual)
Number of subjects: 193
Study: 32672427

Group type: EXPERIMENTAL
Intervention: Renal-replacement therapy initiation timing
Number of subjects: 0
Study: 36169069

Group type: EXPERIMENTAL
Intervention: Pre-filled consent form
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard hand-written consent form
Number of subjects: 0
Study: 33188966

Group type: EXPERIMENTAL
Intervention: Various treatments for lateral ankle sprain
Number of subjects: 74

Group type: COMPARATOR
Intervention: Statistical significance reporting
Number of subjects: 74
Study: 32665265

Group type: EXPERIMENTAL
Intervention: Environmental priming (EP)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Unprimed group
Number of subjects: 52
Study: 32990494

Group type: EXPERIMENTAL
Intervention: Counseling intervention over 4 months
Number of subjects: 85